Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 5 February 1988:
Vol. 239. no. 4840, pp. 604 - 610
DOI: 10.1126/science.3277273

Articles

Science, Vol 239, Issue 4840, 604-610
Copyright © 1988 by American Association for the Advancement of Science


articles

The economic impact of AIDS in the United States

DE Bloom and G Carliner

Columbia University, New York, NY 10027.

This analysis of several previous studies of the cost of AIDS suggests that the lifetime cost of medical care per patient will not exceed +80,000, an amount similar to the cost of treating other serious illnesses. If current projections of future AIDS cases are accurate, the cumulative lifetime costs of 270,000 cases diagnosed between 1981 and the end of 1991 will not exceed +22 billion. This amount is small compared with total U.S. medical spending. The economic impact of AIDS on San Francisco, New York, and some other cities, however, is likely to be more serious. The AIDS epidemic will also highlight the financial problems of Americans who face large medical bills without adequate insurance.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Effects of Quality of Life and Coping on Depression among Adults Living with HIV/AIDS.
C. Gore-Felton, C. Koopman, D. Spiegel, M. Vosvick, M. Brondino, and A. Winningham (2006)
J Health Psychol 11, 711-729
   Abstract »    PDF »
Effect of Relapse to High-Risk Behavior on the Costs and Benefits of a Program to Screen Women for Human Immunodeficiency Virus.
D. K. Owens, M. L. Brandeau, and C. H. Sox (1998)
Interfaces 28, 52-74
   Abstract »    PDF »
The $147,000 Misunderstanding: Repercussions of Overestimating the Cost of AIDS.
J. Green, N. Wintfeld, and G. M. Oppenheimer (1994)
Journal of Health Politics Policy and Law 19, 69-90
   Abstract »    PDF »
Human Immunodeficiency Virus Counseling, Testing, Referral, and Partner Notification Services: A Cost-Benefit Analysis.
D. R. Holtgrave, R. O. Valdiserri, A. R. Gerber, and A. R. Hinman (1993)
Arch Intern Med 153, 1225-1230
   Abstract »    PDF »
From Third World to First World: new roles and challenges for development communication.
S. R. Melkote (1993)
International Communication Gazette 52, 145-158
   Abstract »    PDF »
Cost - Effectiveness of Prophylactic AZT Following Neediestick Injury in Health Care Workers.
S. D. Ramsey and M. D. Nettleman (1992)
Med Decis Making 12, 142-148
   Abstract »    PDF »
Benefits and costs of HIV testing.
D. Bloom and S Glied (1991)
Science 252, 1798-1804
   Abstract »    PDF »
Self-Deferral, HIV Infection, and the Blood Supply: Evaluating an AIDS Intervention.
E. H. Kaplan and A. Novick (1990)
Eval Rev 14, 686-700
   Abstract »    PDF »
The Cost of Acquired Immunodeficiency Syndrome in Northern California: The Experience of a Large Prepaid Health Plan.
R. A. Hiatt, C. P. Quesenberry Jr, J. V. Selby, B. H. Fireman, and A. Knight (1990)
Arch Intern Med 150, 833-838
   Abstract »    PDF »
Clinical Ethics and HIV-Related Illnesses: Issues in Treatment and Health Services Research.
B. Lo (1990)
Med Care Res Rev 47, 15-32
   PDF »
The 1987 US Hospital AIDS Survey.
D. P. Andrulis, V. B. Weslowski, and L. S. Gage (1989)
JAMA 262, 784-794
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)